Facebook
Twitter
Telegram
Report an ErrorKaryopharm Therapeutics Cash Flow 2011-2024 | KPTI
Annual Cash Flow Karyopharm Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-92.7 M | -150 M | -107 M | -160 M | -191 M | -159 M | -73.7 M | -84.4 M | - | - | - | - | - |
Depreciation & Amortization |
530 K | 621 K | 789 K | 972 K | 974 K | 735 K | 713 K | 717 K | 634 K | 323 K | 144 K | 122 K | 83 K |
Accounts Payables |
3.12 M | 2.77 M | 1.6 M | 4.45 M | 985 K | 4.33 M | 5.66 M | 4.75 M | 3.81 M | 6.29 M | 1.74 M | - | - |
Accounts Receivables |
27 M | 47.1 M | 22.5 M | 12.9 M | 7.86 M | - | - | - | - | - | - | - | - |
Total Inventories |
3.04 M | 4.22 M | 4.11 M | 2.64 M | 346 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Karyopharm Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-43.7 M | - | - | - | -18.9 M | - | -123 M | - | -59.2 M | - | -133 M | - | -52.9 M | - | -130 M | -85.3 M | -45 M | - | -151 M | -115 M | -66.6 M | - | -111 M | -72.3 M | -34.7 M | - | -68.2 M | -46.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
85 K | - | - | - | 290 K | - | 508 K | - | 177 K | - | 650 K | - | 235 K | - | 715 K | 480 K | 242 K | - | 730 K | 487 K | 245 K | - | 541 K | 353 K | 169 K | - | 539 K | 363 K | 183 K | - | 537 K | 358 K | 179 K | - | 457 K | 292 K | 136 K | - | 191 K | 85 K | 43 K | - | 106 K | 69 K | 34 K | - | 92 K | - | - | - | - | - | - |
Accounts Payables |
5.03 M | 3.12 M | 943 K | 2.29 M | 9.04 M | 2.77 M | 813 K | - | 3.44 M | 1.6 M | 881 K | 2.31 M | 3.04 M | 4.45 M | 4.45 M | 4.45 M | 4.45 M | 985 K | 985 K | 985 K | 985 K | 4.33 M | 4.33 M | 4.33 M | 4.33 M | 5.66 M | 5.66 M | 5.66 M | 5.66 M | 4.75 M | 4.75 M | 4.75 M | 4.75 M | 3.81 M | 3.81 M | 3.81 M | 3.81 M | 6.29 M | 6.29 M | 6.29 M | 6.29 M | 1.74 M | 1.74 M | 1.74 M | 1.74 M | 1.08 M | 1.08 M | - | - | - | - | - | - |
Accounts Receivables |
31.1 M | 27 M | 37.9 M | 32.3 M | 35.2 M | 47.1 M | 27.4 M | - | 25 M | 22.5 M | 18.8 M | 17.9 M | 17.8 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 7.86 M | 7.86 M | 7.86 M | 7.86 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
2.77 M | 3.04 M | 3.1 M | 3.67 M | 3.83 M | 4.22 M | 4.25 M | - | 3.87 M | 4.11 M | 3.94 M | 3.9 M | 3.11 M | 2.64 M | 2.64 M | 2.64 M | 2.64 M | 346 K | 346 K | 346 K | 346 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency